FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Stem cell research & therapy2019; 10(1); 181; doi: 10.1186/s13287-019-1291-0

Strategies of tenogenic differentiation of equine stem cells for tendon repair: current status and challenges.

Abstract: Tendon injuries, as one of the most common orthopedic disorders, are the major cause of early retirement or wastage among sport horses which mainly affect the superficial digital flexor tendon (SDFT). Tendon repair is a slow process, and tendon tissue is often replaced by scar tissue. The current treatment options are often followed by an incomplete recovery that increases the susceptibility to re-injury. Recently, cell therapy has been used in veterinary medicine to treat tendon injuries, although the risk of ectopic bone formation after cell injection is possible in some cases. In vitro tenogenic induction may overcome the mentioned risk in clinical application. Moreover, a better understanding of treatment strategies for musculoskeletal injuries in horse may have future applications for human and vice versa. This comprehensive review outlines the current strategies of stem cell therapy in equine tendon injury and in vitro tenogenic induction of equine stem cell.
Get Full Text
Publication Date: 2019-06-18 PubMed ID: 31215490PubMed Central: PMC6582602DOI: 10.1186/s13287-019-1291-0Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article discusses current strategies and challenges of using stem cell therapy for tendon repair in horses, focusing on enhancing the healing process and reducing the risk of re-injury.

Overview of Tendon Injuries in Horses

  • Tendon injuries are major causes of early retirements or wastage in sport horses, specifically affecting the superficial digital flexor tendon (SDFT).
  • Recovery from these injuries is generally slow and often results in incomplete healing, with scar tissue replacing the tendon tissue. This subsequently increases susceptibility to future injuries.

Current Treatment Options and Limitations

  • The existing treatment measures often lead to incomplete recovery, making horses prone to re-injuries.
  • The use of cell therapy in veterinary medicine has shown promising results in the treatment of tendon injuries. However, this method carries the risk of ectopic bone formation or the growth of bone in unwanted areas following cell injection.

In Vitro Tenogenic Induction: A Potential Solution

  • One way to mitigate the risk of ectopic bone formation is through in vitro tenogenic induction. This process involves treating the cells in a controlled environment before injecting them into the injured tendon, to ensure that they acquire the necessary properties for tendon repair.
  • Tenogenic induction may make the clinical application of cell therapy safer and more effective for treating tendon injuries.

Significance of Research on Equine Tendon Injuries

  • A comprehensive understanding of treatment strategies for musculoskeletal injuries in horses may have future implications for humans, and vice versa.
  • Therefore, studies on equine tendon injuries not only improve veterinary treatments but may also contribute to advances in human medicine.

In conclusion, this article highlights the potential of stem cell therapy for treating equine tendon injuries. It sheds light on the existing limitations within traditional methods of treatment and projects in vitro tenogenic induction as a potential solution to those challenges.

Cite This Article

APA
Shojaee A, Parham A. (2019). Strategies of tenogenic differentiation of equine stem cells for tendon repair: current status and challenges. Stem Cell Res Ther, 10(1), 181. https://doi.org/10.1186/s13287-019-1291-0

Publication

Stem cell research & therapy
ISSN: 1757-6512
NlmUniqueID: 101527581
Country: England
Language: English
Volume: 10
Issue: 1
Pages: 181

Researcher Affiliations

Shojaee, Asiyeh
  • Division of Physiology, Department of Basic Sciences, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad, Iran.
Parham, Abbas
  • Division of Physiology, Department of Basic Sciences, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad, Iran. Parham@um.ac.ir.
  • Stem Cell Biology and Regenerative Medicine Research Group, Institute of Biotechnology, Ferdowsi University of Mashhad, Mashhad, Iran. Parham@um.ac.ir.

MeSH Terms

  • Animals
  • Cell Differentiation / physiology
  • Cell- and Tissue-Based Therapy / methods
  • Fetal Blood / cytology
  • Horses
  • Stem Cells / cytology
  • Stem Cells / physiology
  • Tendon Injuries / therapy
  • Tissue Engineering / methods

Conflict of Interest Statement

The authors declare that they have no competing interests.

References

This article includes 95 references
  1. Nourissat G, Berenbaum F, Duprez D. Tendon injury: from biology to tendon repair.. Nat Rev Rheumatol 2015;11:223.
    doi: 10.1038/nrrheum.2015.26pubmed: 25734975google scholar: lookup
  2. Schneider M, Angele P, Jarvinen TAH, Docheva D. Rescue plan for Achilles: therapeutics steering the fate and functions of stem cells in tendon wound healing.. Adv Drug Deliv Rev 2018;129:352–375.
    doi: 10.1016/j.addr.2017.12.016pubmed: 29278683google scholar: lookup
  3. Liu H, Zhu S, Zhang C, Lu P, Hu J, Yin Z. Crucial transcription factors in tendon development and differentiation: their potential for tendon regeneration.. Cell Tissue Res 2014;356:287–298.
    doi: 10.1007/s00441-014-1834-8pubmed: 24705622google scholar: lookup
  4. Subramanian A, Schilling TF. Tendon development and musculoskeletal assembly: emerging roles for the extracellular matrix.. Development 2015;142:4191–4204.
    doi: 10.1242/dev.114777pmc: PMC4689213pubmed: 26672092google scholar: lookup
  5. Bavin EP, Smith O, Baird AEG, Smith LC, Guest DJ. Equine induced pluripotent stem cells have a reduced tendon differentiation capacity compared to embryonic stem cells.. Front Vet Sci 2015;2:55.
    doi: 10.3389/fvets.2015.00055pmc: PMC4672282pubmed: 26664982google scholar: lookup
  6. Tempfer H, Traweger A. Tendon vasculature in health and disease.. Front Physiol 2015;6:330.
    doi: 10.3389/fphys.2015.00330pmc: PMC4650849pubmed: 26635616google scholar: lookup
  7. Walden G, Liao X, Donell S, Raxworthy MJ, Riley GP, Saeed A. A clinical, biological, and biomaterials perspective into tendon injuries and regeneration.. Tissue Eng Part B Rev 2017;23:44–58.
    doi: 10.1089/ten.teb.2016.0181pmc: PMC5312458pubmed: 27596929google scholar: lookup
  8. Manske RC. Tendinopathy.. Clinical orthopaedic rehabilitation: a team approach 2018. p. 601–4.
    doi: 10.1016/b978/-0-323-39370-6.00084-6google scholar: lookup
  9. Thorpe CT, Clegg PD, Birch HL. A review of tendon injury: why is the equine superficial digital flexor tendon most at risk?. Equine Vet J 2010;42:174–180.
    doi: 10.2746/042516409X480395pubmed: 20156256google scholar: lookup
  10. O'Brien Etienne J. O., Smith Roger K. W.. Mineralization can be an incidental ultrasonographic finding in equine tendons and ligaments.. Veterinary Radiology & Ultrasound 2018;59(5):613–623.
    doi: 10.1111/vru.12628pubmed: 29776006google scholar: lookup
  11. Patterson-Kane JC, Becker DL, Rich T. The pathogenesis of tendon microdamage in athletes: the horse as a natural model for basic cellular research.. J Comp Pathol 2012;147:227–247.
    doi: 10.1016/j.jcpa.2012.05.010pubmed: 22789861google scholar: lookup
  12. Fortier LA, Smith RKW. Regenerative medicine for tendinous and ligamentous injuries of sport horses.. Vet Clin North Am Equine Pract 2008;24:191–201.
    doi: 10.1016/j.cveq.2007.11.002pubmed: 18314043google scholar: lookup
  13. Koch TG, Berg LC, Betts DH. Current and future regenerative medicine-principles, concepts, and therapeutic use of stem cell therapy and tissue engineering in equine medicine.. Can Vet J 2009;50:155.
    pmc: PMC2629419pubmed: 19412395
  14. Pascucci L, Alessandri G, Dall'Aglio C, Mercati F, Coliolo P, Bazzucchi C. Membrane vesicles mediate pro-angiogenic activity of equine adipose-derived mesenchymal stromal cells.. Vet J 2014;202:361–366.
    doi: 10.1016/j.tvjl.2014.08.021pubmed: 25241947google scholar: lookup
  15. Nixon AJ, Dahlgren LA, Haupt JL, Yeager AE, Ward DL. Effect of adipose-derived nucleated cell fractions on tendon repair in horses with collagenase-induced tendinitis.. Stem Cell Res Ther 2008;69:928–937.
    pubmed: 18593247
  16. Godwin EE, Young NJ, Dudhia J, Beamish IC, Smith RKW. Implantation of bone marrow-derived mesenchymal stem cells demonstrates improved outcome in horses with overstrain injury of the superficial digital flexor tendon.. Equine Vet J 2012;44:25–32.
    doi: 10.1111/j.2042-3306.2011.00363.xpubmed: 21615465google scholar: lookup
  17. Caniglia CJ, Schramme MC, Smith RK. The effect of intralesional injection of bone marrow derived mesenchymal stem cells and bone marrow supernatant on collagen fibril size in a surgical model of equine superficial digital flexor tendonitis.. Equine Vet J 2012;44:587–593.
    doi: 10.1111/j.2042-3306.2011.00514.xpubmed: 22150794google scholar: lookup
  18. de Mattos Carvalho A, Alves ALG, de Oliveira PGG, Alvarez LEC, Amorim RL, Hussni CA. Use of adipose tissue-derived mesenchymal stem cells for experimental tendinitis therapy in equines.. J Equine Vet Sci 2011;31:26–34.
    doi: 10.1016/j.jevs.2010.11.014google scholar: lookup
  19. Carvalho AM, Badial PR, alvarez LEC, Yamada ALM, Borges AS, Deffune E. Equine tendonitis therapy using mesenchymal stem cells and platelet concentrates: a randomized controlled trial.. Stem Cell Res Ther 2013;4:85.
    doi: 10.1186/scrt236pmc: PMC3854756pubmed: 23876512google scholar: lookup
  20. Guercio A, Di Marco P, Casella S, Russotto L, Puglisi F, Majolino C. Mesenchymal stem cells derived from subcutaneous fat and platelet-rich plasma used in athletic horses with lameness of the superficial digital flexor tendon.. J Equine Vet Sci 2015;35:19–26.
    doi: 10.1016/j.jevs.2014.10.006google scholar: lookup
  21. Ricco S, Renzi S, Del Bue M, Conti V, Merli E, Ramoni R. Allogeneic adipose tissue-derived mesenchymal stem cells in combination with platelet rich plasma are safe and effective in the therapy of superficial digital flexor tendonitis in the horse.. Int J Immunopathol Pharmacol 2013;26:61–68.
    doi: 10.1177/03946320130260S108pubmed: 24046950google scholar: lookup
  22. Geburek F, Mundle K, Conrad S, Hellige M, Walliser U, van Schie HTM. Tracking of autologous adipose tissue-derived mesenchymal stromal cells with in vivo magnetic resonance imaging and histology after intralesional treatment of artificial equine tendon lesions-a pilot study.. Stem Cell Res Ther 2016;7:21.
    doi: 10.1186/s13287-016-0281-8pmc: PMC4736260pubmed: 26830812google scholar: lookup
  23. Burk J, Berner D, Brehm W, Hillmann A, Horstmeier C, Josten C. Long-term cell tracking following local injection of mesenchymal stromal cells in the equine model of induced tendon disease.. Cell Transplant 2016;25:2199–2211.
    doi: 10.3727/096368916X692104pubmed: 27392888google scholar: lookup
  24. Ahrberg AB, Horstmeier C, Berner D, Brehm W, Gittel C, Hillmann A. Effects of mesenchymal stromal cells versus serum on tendon healing in a controlled experimental trial in an equine model.. BMC Musculoskelet Disord 2018;19:230.
    doi: 10.1186/s12891-018-2163-ypmc: PMC6052633pubmed: 30021608google scholar: lookup
  25. Van Loon VJF, Scheffer CJW, Genn HJ, Hoogendoorn AC, Greve JW. Clinical follow-up of horses treated with allogeneic equine mesenchymal stem cells derived from umbilical cord blood for different tendon and ligament disorders.. Vet Q 2014;34:92–97.
    doi: 10.1080/01652176.2014.949390pubmed: 25072527google scholar: lookup
  26. Muttini A, Valbonetti L, Abate M, Colosimo A, Curini V, Mauro A. Ovine amniotic epithelial cells: in vitro characterization and transplantation into equine superficial digital flexor tendon spontaneous defects.. Res Vet Sci 2013;94:158–169.
    doi: 10.1016/j.rvsc.2012.07.028pubmed: 22954787google scholar: lookup
  27. Muttini A, Russo V, Rossi E, Mattioli M, Barboni B, Tosi U. Pilot experimental study on amniotic epithelial mesenchymal cell transplantation in natural occurring tendinopathy in horses. Ultrasonographic and histological comparison.. Muscles Ligaments Tendons J 2015;5:5.
    doi: 10.32098/mltj.01.2015.02pmc: PMC4396678pubmed: 25878980google scholar: lookup
  28. Guest DJ, Smith MRW, Allen WR. Equine embryonic stem-like cells and mesenchymal stromal cells have different survival rates and migration patterns following their injection into damaged superficial digital flexor tendon.. Equine Vet J 2010;42:636–642.
    doi: 10.1111/j.2042-3306.2010.00112.xpubmed: 20840579google scholar: lookup
  29. Schnabel LV, Lynch ME, Van Der Meulen MCH, Yeager AE, Kornatowski MA, Nixon AJ. Mesenchymal stem cells and insulin-like growth factor-I gene-enhanced mesenchymal stem cells improve structural aspects of healing in equine flexor digitorum superficialis tendons.. J Orthop Res 2009;27:1392–1398.
    doi: 10.1002/jor.20887pubmed: 19350658google scholar: lookup
  30. Beerts C, Suls M, Broeckx SY, Seys B, Al V, Declercq J. Tenogenically induced allogeneic peripheral blood mesenchymal stem cells in allogeneic platelet-rich plasma: 2-year follow-up after tendon or ligament treatment in horses.. Front Vet Sci 2017;4:158.
    doi: 10.3389/fvets.2017.00158pmc: PMC5622984pubmed: 29018808google scholar: lookup
  31. Broeckx S, Zimmerman M, Aerts D, Seys B, Suls M, Marien T. Tenogenesis of equine peripheral blood-derived mesenchymal stem cells: in vitro versus in vivo.. J Tissue Sci Eng 2012;11:1–6.
  32. Durgam SS, Stewart AA, Sivaguru M, Wagoner Johnson AJ, Stewart MC. Tendon-derived progenitor cells improve healing of collagenase-induced flexor tendinitis.. J Orthop Res 2016;34:2162–2171.
    doi: 10.1002/jor.23251pubmed: 27035120google scholar: lookup
  33. Burk J, Gittel C, Heller S, Pfeiffer B, Paebst F, Ahrberg AB. Gene expression of tendon markers in mesenchymal stromal cells derived from different sources.. BMC Res Notes 2014;7:826.
    doi: 10.1186/1756-0500-7-826pmc: PMC4247609pubmed: 25412928google scholar: lookup
  34. Koch TG, Heerkens T, Thomsen PD, Betts DH. Isolation of mesenchymal stem cells from equine umbilical cord blood.. BMC Biotechnol 2007;7:26.
    doi: 10.1186/1472-6750-7-26pmc: PMC1904213pubmed: 17537254google scholar: lookup
  35. Hoynowski SM, Fry MM, Gardner BM, Leming MT, Tucker JR, Black L. Characterization and differentiation of equine umbilical cord-derived matrix cells.. Biochem Biophys Res Commun 2007;362:347–353.
    doi: 10.1016/j.bbrc.2007.07.182pubmed: 17719011google scholar: lookup
  36. De Schauwer C, Van de Walle GR, Van Soom A, Meyer E. Mesenchymal stem cell therapy in horses: useful beyond orthopedic injuries?. Vet Q 2013;33:234–241.
    doi: 10.1080/01652176.2013.800250pubmed: 23697553google scholar: lookup
  37. Burk J, Ribitsch I, Gittel C, Juelke H, Kasper C, Staszyk C. Growth and differentiation characteristics of equine mesenchymal stromal cells derived from different sources.. Vet J 2013;195:98–106.
    doi: 10.1016/j.tvjl.2012.06.004pubmed: 22841420google scholar: lookup
  38. Youngstrom DW, LaDow JE, Barrett JG. Tenogenesis of bone marrow-, adipose-, and tendon-derived stem cells in a dynamic bioreactor.. Connect Tissue Res 2016;57:454–465.
    doi: 10.3109/03008207.2015.1117458pubmed: 27028488google scholar: lookup
  39. Grier WK, Iyoha EM, Harley BAC. The influence of pore size and stiffness on tenocyte bioactivity and transcriptomic stability in collagen-GAG scaffolds.. J Mech Behav Biomed Mater 2017;65:295–305.
    doi: 10.1016/j.jmbbm.2016.08.034pmc: PMC5154820pubmed: 27614271google scholar: lookup
  40. Theiss F, Mirsaidi A, Mhanna R, Kummerle J, Glanz S, Bahrenberg G. Use of biomimetic microtissue spheroids and specific growth factor supplementation to improve tenocyte differentiation and adaptation to a collagen-based scaffold in vitro.. Biomaterials 2015;69:99–109.
    doi: 10.1016/j.biomaterials.2015.08.013pubmed: 26283157google scholar: lookup
  41. Barsby T, Guest D. Transforming growth factor beta3 promotes tendon differentiation of equine embryo-derived stem cells.. Tissue Eng Part A 2013;19:2156–2165.
    doi: 10.1089/ten.tea.2012.0372pubmed: 23611525google scholar: lookup
  42. Saito S, Ugai H, Sawai K, Yamamoto Y, Minamihashi A, Kurosaka K. Isolation of embryonic stem-like cells from equine blastocysts and their differentiation in vitro1.. FEBS Lett 2002;531:389–396.
    doi: 10.1016/S0014-5793(02)03550-0pubmed: 12435581google scholar: lookup
  43. Watts AE, Yeager AE, Kopyov OV, Nixon AJ. Fetal derived embryonic-like stem cells improve healing in a large animal flexor tendonitis model.. Stem Cell Res Ther 2011;2:4.
    doi: 10.1186/scrt45pmc: PMC3092144pubmed: 21272343google scholar: lookup
  44. Breton A, Sharma R, Diaz AC, Parham AG, Graham A, Neil C. Derivation and characterization of induced pluripotent stem cells from equine fibroblasts.. Stem Cells Dev 2012;22:611–621.
    doi: 10.1089/scd.2012.0052pmc: PMC3564467pubmed: 22897112google scholar: lookup
  45. Nagy K, Sung H-K, Zhang P, Laflamme S, Vincent P, Agha-Mohammadi S. Induced pluripotent stem cell lines derived from equine fibroblasts.. Stem Cell Rev 2011;7:693–702.
    doi: 10.1007/s12015-011-9239-5pmc: PMC3137777pubmed: 21347602google scholar: lookup
  46. Mundra V, Gerling IC, Mahato RI. Mesenchymal stem cell-based therapy.. Mol Pharm 2012;10:77–89.
    doi: 10.1021/mp3005148pmc: PMC3549356pubmed: 23215004google scholar: lookup
  47. Burk J, Badylak SF, Kelly J, Brehm W. Equine cellular therapy-from stall to bench to bedside?. Cytometry A 2013;83:103–113.
    doi: 10.1002/cyto.a.22216pubmed: 23081833google scholar: lookup
  48. Alves LG, de Mattos Carvalho A, A Hussni C. Mesenchymal stem cell therapy for equine tendinitis.. Recent Pat Regen Med 2013;3:103–110.
  49. Geburek F, Lietzau M, Beineke A, Rohn K, Stadler PM. Effect of a single injection of autologous conditioned serum (ACS) on tendon healing in equine naturally occurring tendinopathies.. Stem Cell Res Ther 2015;6:126.
    doi: 10.1186/s13287-015-0115-0pmc: PMC4513386pubmed: 26113022google scholar: lookup
  50. Guest DJ, Smith MRW, Allen WR. Monitoring the fate of autologous and allogeneic mesenchymal progenitor cells injected into the superficial digital flexor tendon of horses: preliminary study.. Equine Vet J 2008;40:178–181.
    doi: 10.2746/042516408X276942pubmed: 18267891google scholar: lookup
  51. Al V, Broeckx SY, Beerts C, Seys B, Zimmerman M, Verweire I. Tenogenically induced allogeneic mesenchymal stem cells for the treatment of proximal suspensory ligament desmitis in a horse.. Front Vet Sci 2015;2:49.
    pmc: PMC4672201pubmed: 26664976
  52. Geburek F, Roggel F, van Schie HTM, Beineke A, Estrada R, Weber K. Effect of single intralesional treatment of surgically induced equine superficial digital flexor tendon core lesions with adipose-derived mesenchymal stromal cells: a controlled experimental trial.. Stem Cell Res Ther 2017;8:129.
    doi: 10.1186/s13287-017-0564-8pmc: PMC5460527pubmed: 28583184google scholar: lookup
  53. Smith RKW, Korda M, Blunn GW, Goodship AE. Isolation and implantation of autologous equine mesenchymal stem cells from bone marrow into the superficial digital flexor tendon as a potential novel treatment.. Equine Vet J 2003;35:99–102.
    doi: 10.2746/042516403775467388pubmed: 12553472google scholar: lookup
  54. Garvican ER, Cree S, Bull L, Smith RKW, Dudhia J. Viability of equine mesenchymal stem cells during transport and implantation.. Stem Cell Res Ther 2014;5:1.
    doi: 10.1186/scrt483pmc: PMC4247703pubmed: 25107289google scholar: lookup
  55. Becerra P, Valdas Vazquez MA, Dudhia J, Fiske-Jackson AR, Neves F, Hartman NG. Distribution of injected technetium99m-labeled mesenchymal stem cells in horses with naturally occurring tendinopathy.. J Orthop Res 2013;31:1096–1102.
    doi: 10.1002/jor.22338pubmed: 23508674google scholar: lookup
  56. Sole A, Spriet M, Padgett KA, Vaughan B, Galuppo LD, Borjesson DL. Distribution and persistence of technetium-99 hexamethyl propylene amine oxime-labelled bone marrow-derived mesenchymal stem cells in experimentally induced tendon lesions after intratendinous injection and regional perfusion of the equine distal limb.. Equine Vet J 2013;45:726–731.
    doi: 10.1111/evj.12063pubmed: 23574488google scholar: lookup
  57. Fang Z, Zhu T, Shen WL, Tang QM, Chen JL, Yin Z. Transplantation of fetal instead of adult fibroblasts reduces the probability of ectopic ossification during tendon repair.. Tissue Eng Part A 2012;20:1815–1826.
    doi: 10.1089/ten.tea.2013.0296pmc: PMC4086799pubmed: 24410299google scholar: lookup
  58. Harris MT, Butler DL, Boivin GP, Florer JB, Schantz EJ, Wenstrup RJ. Mesenchymal stem cells used for rabbit tendon repair can form ectopic bone and express alkaline phosphatase activity in constructs.. J Orthop Res 2004;22:998–1003.
    doi: 10.1016/j.orthres.2004.02.012pubmed: 15304271google scholar: lookup
  59. Becker Ann De, Riet Ivan Van. Homing and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy?. World Journal of Stem Cells 2016;8(3):73.
    doi: 10.4252/wjsc.v8.i3.73pmc: PMC4807311pubmed: 27022438google scholar: lookup
  60. James R, Kesturu G, Balian G, Chhabra AB. Tendon: biology, biomechanics, repair, growth factors, and evolving treatment options.. J Hand Surg Am 2008;33:102–112.
    doi: 10.1016/j.jhsa.2007.09.007pubmed: 18261674google scholar: lookup
  61. Torricelli P, Fini M, Filardo G, Tschon M, Pischedda M, Pacorini A. Regenerative medicine for the treatment of musculoskeletal overuse injuries in competition horses.. Int Orthop 2011;35:1569–1576.
    doi: 10.1007/s00264-011-1237-3pmc: PMC3174295pubmed: 21394594google scholar: lookup
  62. Barsby T, Bavin EP, Guest DJ. Three-dimensional culture and transforming growth factor beta3 synergistically promote tenogenic differentiation of equine embryo-derived stem cells.. Tissue Eng Part A 2014;20:2604–2613.
    doi: 10.1089/ten.tea.2013.0457pmc: PMC4195467pubmed: 24628376google scholar: lookup
  63. Gulati BR, Kumar R, Mohanty N, Kumar P, Somasundaram RK, Yadav PS. Bone morphogenetic protein-12 induces tenogenic differentiation of mesenchymal stem cells derived from equine amniotic fluid.. Cells Tissues Organs 2013;198:377–389.
    doi: 10.1159/000358231pubmed: 24662023google scholar: lookup
  64. Violini S, Ramelli P, Pisani LF, Gorni C, Mariani P. Horse bone marrow mesenchymal stem cells express embryo stem cell markers and show the ability for tenogenic differentiation by in vitro exposure to BMP-12.. BMC Cell Biol 2009;10:29.
    doi: 10.1186/1471-2121-10-29pmc: PMC2678092pubmed: 19383177google scholar: lookup
  65. Mohanty N, Gulati BR, Kumar R, Gera S, Kumar P, Somasundaram RK. Immunophenotypic characterization and tenogenic differentiation of mesenchymal stromal cells isolated from equine umbilical cord blood.. In Vitro Cell Dev Biol Anim 2014;50:538–548.
    doi: 10.1007/s11626-013-9729-7pubmed: 24414976google scholar: lookup
  66. Gomiero C, Bertolutti G, Martinello T, Van Bruaene N, Broeckx SY, Patruno M. Tenogenic induction of equine mesenchymal stem cells by means of growth factors and low-level laser technology.. Vet Res Commun 2016;40:39–48.
    doi: 10.1007/s11259-016-9652-ypubmed: 26757735google scholar: lookup
  67. Caliari SR, Harley BAC. Composite growth factor supplementation strategies to enhance tenocyte bioactivity in aligned collagen-GAG scaffolds.. Tissue Eng Part A 2013;19:1100–1112.
    doi: 10.1089/ten.tea.2012.0497pmc: PMC3609632pubmed: 23157454google scholar: lookup
  68. Raabe O, Shell K, Fietz D, Freitag C, Ohrndorf A, Christ HJ. Tenogenic differentiation of equine adipose-tissue-derived stem cells under the influence of tensile strain, growth differentiation factors and various oxygen tensions.. Cell Tissue Res 2013;352:509–521.
    doi: 10.1007/s00441-013-1574-1pubmed: 23430474google scholar: lookup
  69. Durgam SS, Stewart AA, Pondenis HC, Gutierrez-Nibeyro SM, Evans RB, Stewart MC. Comparison of equine tendon-and bone marrow-derived cells cultured on tendon matrix with or without insulin-like growth factor-I supplementation.. Am J Vet Res 2012;73:153–161.
    doi: 10.2460/ajvr.73.1.153pubmed: 22204302google scholar: lookup
  70. Lovati AB, Corradetti B, Cremonesi F, Bizzaro D, Consiglio AL. Tenogenic differentiation of equine mesenchymal progenitor cells under indirect co-culture.. Int J Artif Organs 2012;35:996–1005.
    doi: 10.1177/039139881203501105pubmed: 23065882google scholar: lookup
  71. Lange-Consiglio A, Rossi D, Tassan S, Perego R, Cremonesi F, Parolini O. Conditioned medium from horse amniotic membrane-derived multipotent progenitor cells: immunomodulatory activity in vitro and first clinical application in tendon and ligament injuries in vivo.. Stem Cells Dev 2012;22:3015–3024.
    doi: 10.1089/scd.2013.0214pubmed: 23795963google scholar: lookup
  72. Gattazzo F, Urciuolo A, Bonaldo P. Extracellular matrix: a dynamic microenvironment for stem cell niche.. Biochim Biophys Acta Gen Subj 2014;1840:2506–2519.
    doi: 10.1016/j.bbagen.2014.01.010pmc: PMC4081568pubmed: 24418517google scholar: lookup
  73. Reed SA, Johnson SE. Expression of scleraxis and tenascin C in equine adipose and umbilical cord blood derived stem cells is dependent upon substrata and FGF supplementation.. Cytotechnology 2014;66:27–35.
    doi: 10.1007/s10616-012-9533-3pmc: PMC3886543pubmed: 23299298google scholar: lookup
  74. Ker EDF, Chu B, Phillippi JA, Gharaibeh B, Huard J, Weiss LE. Engineering spatial control of multiple differentiation fates within a stem cell population.. Biomaterials 2011;32:3413–3422.
    doi: 10.1016/j.biomaterials.2011.01.036pmc: PMC3060662pubmed: 21316755google scholar: lookup
  75. Wilgus TA. Growth factor-extracellular matrix interactions regulate wound repair.. Adv Wound Care 2012;1:249–254.
    doi: 10.1089/wound.2011.0344pmc: PMC3623585pubmed: 24527314google scholar: lookup
  76. Burk J, Erbe I, Berner D, Kacza J, Kasper C, Pfeiffer B. Freeze-thaw cycles enhance decellularization of large tendons.. Tissue Eng Part C Methods 2013;20:276–284.
    doi: 10.1089/ten.tec.2012.0760pmc: PMC3968887pubmed: 23879725google scholar: lookup
  77. Stewart AA, Barrett JG, Byron CR, Yates AC, Durgam SS, Evans RB. Comparison of equine tendon-, muscle-, and bone marrow-derived cells cultured on tendon matrix.. Am J Vet Res 2009;70:750–757.
    doi: 10.2460/ajvr.70.6.750pubmed: 19496665google scholar: lookup
  78. Caliari SR, Weisgerber DW, Ramirez MA, Kelkhoff DO, Harley BAC. The influence of collagen-glycosaminoglycan scaffold relative density and microstructural anisotropy on tenocyte bioactivity and transcriptomic stability.. J Mech Behav Biomed Mater 2012;11:27–40.
    doi: 10.1016/j.jmbbm.2011.12.004pmc: PMC3947516pubmed: 22658152google scholar: lookup
  79. Popielarczyk TL, Nain AS, Barrett JG. Aligned nanofiber topography directs the tenogenic differentiation of mesenchymal stem cells.. Appl Sci 2017;7:59.
    doi: 10.3390/app7010059google scholar: lookup
  80. Schiele NR, Marturano JE, Kuo CK. Mechanical factors in embryonic tendon development: potential cues for stem cell tenogenesis.. Curr Opin Biotechnol 2013;24:834–840.
    doi: 10.1016/j.copbio.2013.07.003pmc: PMC3813901pubmed: 23916867google scholar: lookup
  81. Youngstrom DW, Rajpar I, Kaplan DL, Barrett JG. A bioreactor system for in vitro tendon differentiation and tendon tissue engineering.. J Orthop Res 2015;33:911–918.
    doi: 10.1002/jor.22848pmc: PMC5098427pubmed: 25664422google scholar: lookup
  82. Burk J, Plenge A, Brehm W, Heller S, Pfeiffer B, Kasper C. Induction of tenogenic differentiation mediated by extracellular tendon matrix and short-term cyclic stretching.. Stem Cells Int 2016;2016(Article ID 7342379):11.
    doi: 10.1155/2016/7342379pmc: PMC5007347pubmed: 27630718google scholar: lookup
  83. Peat FJ, Colbath AC, Bentsen LM, Goodrich LR, King MR. In vitro effects of high-intensity laser photobiomodulation on equine bone marrow-derived mesenchymal stem cell viability and cytokine expression.. Photomed Laser Surg 2018;36:83–91.
    doi: 10.1089/pho.2017.4344pubmed: 29131717google scholar: lookup
  84. Husby KA. In vitro evaluation of therapeutic laser treatment on equine tendon fibroblasts.. 2016.
  85. Murray SJ, Santangelo KS, Bertone AL. Evaluation of early cellular influences of bone morphogenetic proteins 12 and 2 on equine superficial digital flexor tenocytes and bone marrow-derived mesenchymal stem cells in vitro.. Am J Vet Res 2010;71:103–114.
    doi: 10.2460/ajvr.71.1.103pmc: PMC4246500pubmed: 20043789google scholar: lookup
  86. Millar NL, Watts AE, Akbar M, Hughes T, Kitson S, Gilchrist DS. MicroRNA-29a in equine tendinopathy-a translational target.. Equine Vet J 2016;48:27.
    pubmed: 0
  87. Lange-Consiglio A, Lazzari B, Perrini C, Pizzi F, Stella A, Cremonesi F. MicroRNAs of equine amniotic mesenchymal cell-derived microvesicles and their involvement in anti-inflammatory processes.. Cell Transplant 2018;27:45–54.
    doi: 10.1177/0963689717724796pmc: PMC6434479pubmed: 29562776google scholar: lookup
  88. Bavin EP, Atkinson F, Barsby T, Guest DJ. Scleraxis is essential for tendon differentiation by equine embryonic stem cells and in equine fetal tenocytes.. Stem Cells Dev 2017;26:441–450.
    doi: 10.1089/scd.2016.0279pubmed: 27899062google scholar: lookup
  89. Nichols AEC, Settlage RE, Werre SR, Dahlgren LA. Novel roles for scleraxis in regulating adult tenocyte function.. BMC Cell Biol 2018;19:14.
    doi: 10.1186/s12860-018-0166-zpmc: PMC6081934pubmed: 30086712google scholar: lookup
  90. Ranera B, Remacha AR, Avarez-Arguedas S, Romero A, Vazquez FJ, Zaragoza P. Effect of hypoxia on equine mesenchymal stem cells derived from bone marrow and adipose tissue.. BMC Vet Res 2012;8:142.
    doi: 10.1186/1746-6148-8-142pmc: PMC3483288pubmed: 22913590google scholar: lookup
  91. Shell K, Raabe O, Freitag C, Ohrndorf A, Christ H-J, Wenisch S. Comparison of equine adipose tissue-derived stem cell behavior and differentiation potential under the influence of 3% and 21% oxygen tension.. J Equine Vet Sci 2013;33:74–82.
    doi: 10.1016/j.jevs.2012.05.002pubmed: 23430474google scholar: lookup
  92. Lui PPY, Maffulli N, Rolf C, Smith RKW. What are the validated animal models for tendinopathy?. Scand J Med Sci Sports 2011;21:3–17.
    doi: 10.1111/j.1600-0838.2010.01164.xpubmed: 20673247google scholar: lookup
  93. Hillmann A, Ahrberg AB, Brehm W, Heller S, Josten C, Paebst F. Comparative characterization of human and equine mesenchymal stromal cells: a basis for translational studies in the equine model.. Cell Transplant 2016;25:109–124.
    doi: 10.3727/096368915X687822pubmed: 25853993google scholar: lookup
  94. Zahedi M, Parham A, Dehghani H, Mehrjerdi HK. Stemness signature of equine marrow-derived mesenchymal stem cells.. Int J Stem Cells 2017;10:93.
    doi: 10.15283/ijsc16036pmc: PMC5488781pubmed: 28222255google scholar: lookup
  95. Kornicka K, Houston J, Marycz K. Dysfunction of mesenchymal stem cells isolated from metabolic syndrome and type 2 diabetic patients as result of oxidative stress and autophagy may limit their potential therapeutic use.. Stem Cell Rev 2018;14:337–345.
    doi: 10.1007/s12015-018-9809-xpmc: PMC5960487pubmed: 29611042google scholar: lookup

Citations

This article has been cited 29 times.
  1. Sabzpoosh M, Hoveizi E, Gooraninejad S. Isolation and differentiation of endometrial mesenchymal stem cells from Arabian mares. In Vitro Cell Dev Biol Anim 2025 Dec;61(10):1187-1192.
    doi: 10.1007/s11626-025-01103-5pubmed: 41288937google scholar: lookup
  2. Tommasa SD, Raspe S, Farí G, Imperante A, Brehm W. Autologous conditioned serum IRAP efficacy for tendon and ligament injuries in horses: An observational study. Open Vet J 2025;15(8):3787-3793.
    doi: 10.5455/OVJ.2025.v15.i8.43pubmed: 41036008google scholar: lookup
  3. Shi L, Khan MZ, Ullah A, Liang H, Geng M, Akhtar MF, Na J, Han Y, Wang C. Advancements in Stem Cell Applications for Livestock Research: A Review. Vet Sci 2025 Apr 23;12(5).
    doi: 10.3390/vetsci12050397pubmed: 40431490google scholar: lookup
  4. Morawska-Kozłowska M, Pitas M, Zhalniarovich Y. Mesenchymal Stem Cells in Veterinary Medicine-Still Untapped Potential. Animals (Basel) 2025 Apr 19;15(8).
    doi: 10.3390/ani15081175pubmed: 40282009google scholar: lookup
  5. Trapana J, Weinerman J, Lee D, Sedani A, Constantinescu D, Best TM, Hornicek FJ Jr, Hare JM. Cell-based therapy in the treatment of musculoskeletal diseases. Stem Cells Transl Med 2024 Oct 10;13(10):959-978.
    doi: 10.1093/stcltm/szae049pubmed: 39226104google scholar: lookup
  6. Dec P, Żyłka M, Burszewski P, Modrzejewski A, Pawlik A. Recent Advances in the Use of Stem Cells in Tissue Engineering and Adjunct Therapies for Tendon Reconstruction and Future Perspectives. Int J Mol Sci 2024 Apr 19;25(8).
    doi: 10.3390/ijms25084498pubmed: 38674084google scholar: lookup
  7. Ma S, Zheng S, Li D, Hu W, Wang L. Melt Electrowriting Combined with Fused Deposition Modeling Printing for the Fabrication of Three-Dimensional Biomimetic Scaffolds for Osteotendinous Junction Regeneration. Int J Nanomedicine 2024;19:3275-3293.
    doi: 10.2147/IJN.S449952pubmed: 38601348google scholar: lookup
  8. De Castilho T, Rosa GDS, Stievani FC, Apolônio EVP, Pfeifer JPH, Altheman VG, Palialogo V, Santos NJD, Fonseca-Alves CE, Alves ALG. Biocompatibility of hydrogel derived from equine tendon extracellular matrix in horses subcutaneous tissue. Front Bioeng Biotechnol 2023;11:1296743.
    doi: 10.3389/fbioe.2023.1296743pubmed: 38260745google scholar: lookup
  9. Taguchi T, Lopez M, Takawira C. Viable tendon neotissue from adult adipose-derived multipotent stromal cells. Front Bioeng Biotechnol 2023;11:1290693.
    doi: 10.3389/fbioe.2023.1290693pubmed: 38260742google scholar: lookup
  10. Chen J, Jiang C, Yin L, Liu Y, He Y, Li S, Shen H. A Review of the Role of Tendon Stem Cells in Tendon-Bone Regeneration. Med Sci Monit 2023 Sep 16;29:e940805.
    doi: 10.12659/MSM.940805pubmed: 37715366google scholar: lookup
  11. Petrova V, Yonkova P, Simeonova G, Vachkova E. Horse serum potentiates cellular viability and improves indomethacin-induced adipogenesis in equine subcutaneous adipose-derived stem cells (ASCs). Int J Vet Sci Med 2023;11(1):94-105.
    doi: 10.1080/23144599.2023.2248805pubmed: 37655053google scholar: lookup
  12. Shojaee A. Equine tendon mechanical behaviour: Prospects for repair and regeneration applications. Vet Med Sci 2023 Sep;9(5):2053-2069.
    doi: 10.1002/vms3.1205pubmed: 37471573google scholar: lookup
  13. Jiang L, Lu J, Chen Y, Lyu K, Long L, Wang X, Liu T, Li S. Mesenchymal stem cells: An efficient cell therapy for tendon repair (Review). Int J Mol Med 2023 Aug;52(2).
    doi: 10.3892/ijmm.2023.5273pubmed: 37387410google scholar: lookup
  14. Petrova V, Vachkova E. Outlook of Adipose-Derived Stem Cells: Challenges to Their Clinical Application in Horses. Vet Sci 2023 May 12;10(5).
    doi: 10.3390/vetsci10050348pubmed: 37235430google scholar: lookup
  15. Leal Reis I, Lopes B, Sousa P, Sousa AC, Branquinho M, Caseiro AR, Pedrosa SS, Rêma A, Oliveira C, Porto B, Atayde L, Amorim I, Alvites R, Santos JM, Maurício AC. Allogenic Synovia-Derived Mesenchymal Stem Cells for Treatment of Equine Tendinopathies and Desmopathies-Proof of Concept. Animals (Basel) 2023 Apr 11;13(8).
    doi: 10.3390/ani13081312pubmed: 37106875google scholar: lookup
  16. Yuan Z, Yu H, Long H, Dai Y, Shi L, Zhao J, Guo A, Diao N, Ma L, Yin H. Stem Cell Applications and Tenogenic Differentiation Strategies for Tendon Repair. Stem Cells Int 2023;2023:3656498.
    doi: 10.1155/2023/3656498pubmed: 36970597google scholar: lookup
  17. Bowers K, Amelse L, Bow A, Newby S, MacDonald A, Sun X, Anderson D, Dhar M. Mesenchymal Stem Cell Use in Acute Tendon Injury: In Vitro Tenogenic Potential vs. In Vivo Dose Response. Bioengineering (Basel) 2022 Aug 22;9(8).
    doi: 10.3390/bioengineering9080407pubmed: 36004932google scholar: lookup
  18. Makuku R, Werthel JD, Zanjani LO, Nabian MH, Tantuoyir MM. New frontiers of tendon augmentation technology in tissue engineering and regenerative medicine: a concise literature review. J Int Med Res 2022 Aug;50(8):3000605221117212.
    doi: 10.1177/03000605221117212pubmed: 35983666google scholar: lookup
  19. Supokawej A, Korchunjit W, Wongtawan T. The combination of BMP12 and KY02111 enhances tendon differentiation in bone marrow-derived equine mesenchymal stromal cells (BM-eMSCs). J Equine Sci 2022 Jul;33(2):19-26.
    doi: 10.1294/jes.33.19pubmed: 35847484google scholar: lookup
  20. Xue Y, Kim HJ, Lee J, Liu Y, Hoffman T, Chen Y, Zhou X, Sun W, Zhang S, Cho HJ, Lee J, Kang H, Ryu W, Lee CM, Ahadian S, Dokmeci MR, Lei B, Lee K, Khademhosseini A. Co-Electrospun Silk Fibroin and Gelatin Methacryloyl Sheet Seeded with Mesenchymal Stem Cells for Tendon Regeneration. Small 2022 May;18(21):e2107714.
    doi: 10.1002/smll.202107714pubmed: 35487761google scholar: lookup
  21. Depuydt E, Broeckx SY, Chiers K, Patruno M, Da Dalt L, Duchateau L, Saunders J, Pille F, Martens A, Van Hecke L, Spaas JH. Cellular and Humoral Immunogenicity Investigation of Single and Repeated Allogeneic Tenogenic Primed Mesenchymal Stem Cell Treatments in Horses Suffering From Tendon Injuries. Front Vet Sci 2021;8:789293.
    doi: 10.3389/fvets.2021.789293pubmed: 35281431google scholar: lookup
  22. Li ZJ, Yang QQ, Zhou YL. Basic Research on Tendon Repair: Strategies, Evaluation, and Development. Front Med (Lausanne) 2021;8:664909.
    doi: 10.3389/fmed.2021.664909pubmed: 34395467google scholar: lookup
  23. Meeremans M, Van de Walle GR, Van Vlierberghe S, De Schauwer C. The Lack of a Representative Tendinopathy Model Hampers Fundamental Mesenchymal Stem Cell Research. Front Cell Dev Biol 2021;9:651164.
    doi: 10.3389/fcell.2021.651164pubmed: 34012963google scholar: lookup
  24. Depuydt E, Broeckx SY, Van Hecke L, Chiers K, Van Brantegem L, van Schie H, Beerts C, Spaas JH, Pille F, Martens A. The Evaluation of Equine Allogeneic Tenogenic Primed Mesenchymal Stem Cells in a Surgically Induced Superficial Digital Flexor Tendon Lesion Model. Front Vet Sci 2021;8:641441.
    doi: 10.3389/fvets.2021.641441pubmed: 33748217google scholar: lookup
  25. Ribitsch I, Oreff GL, Jenner F. Regenerative Medicine for Equine Musculoskeletal Diseases. Animals (Basel) 2021 Jan 19;11(1).
    doi: 10.3390/ani11010234pubmed: 33477808google scholar: lookup
  26. Bagge J, MacLeod JN, Berg LC. Cellular Proliferation of Equine Bone Marrow- and Adipose Tissue-Derived Mesenchymal Stem Cells Decline With Increasing Donor Age. Front Vet Sci 2020;7:602403.
    doi: 10.3389/fvets.2020.602403pubmed: 33363241google scholar: lookup
  27. Bukowska J, Szóstek-Mioduchowska AZ, Kopcewicz M, Walendzik K, Machcińska S, Gawrońska-Kozak B. Adipose-Derived Stromal/Stem Cells from Large Animal Models: from Basic to Applied Science. Stem Cell Rev Rep 2021 Jun;17(3):719-738.
    doi: 10.1007/s12015-020-10049-ypubmed: 33025392google scholar: lookup
  28. Citeroni MR, Ciardulli MC, Russo V, Della Porta G, Mauro A, El Khatib M, Di Mattia M, Galesso D, Barbera C, Forsyth NR, Maffulli N, Barboni B. In Vitro Innovation of Tendon Tissue Engineering Strategies. Int J Mol Sci 2020 Sep 14;21(18).
    doi: 10.3390/ijms21186726pubmed: 32937830google scholar: lookup
  29. Paterson YZ, Cribbs A, Espenel M, Smith EJ, Henson FMD, Guest DJ. Genome-wide transcriptome analysis reveals equine embryonic stem cell-derived tenocytes resemble fetal, not adult tenocytes. Stem Cell Res Ther 2020 May 19;11(1):184.
    doi: 10.1186/s13287-020-01692-wpubmed: 32430075google scholar: lookup
Subscribe to our newsletter
Join 99,780 horse owners like you who receive our email updates on horse health and nutrition.